Managing Director (Clinical Trials Centre, The University of Hong Kong), Chief Executive Officer (The University of Hong Kong Clinical Trials Centre (China)), Honorary Assistant Professor (Faculty of Medicine, Macau University of Science and Technology)
Henry Yau is the Chief Executive Officer of The University of Hong Kong Clinical Trials Centre (China) (HKU-CTCC), Managing Director of Clinical Trials Centre, The University of Hong Kong (HKU-CTC), Honorary Assistant Professor of Faculty of Medicine of Macau University of Science and Technology (MUST). He holds a B.Sc. in Biochemistry and a MBA in Finance. Started his career in the pharmaceutical industry in early-1990s, Henry has been specializing in clinical research management for over two decades since 2000. Henry has also been recognized as a High-end Foreign Expert (Clinical Trials Management) under the National High-end Foreign Experts Recruitment Plan of the Chinese Ministry of Science & Technology (MOST) since early-2023, and undertakes roles in many local and international bodies such as Steering Board Member and Past Chairperson of the International Clinical Trial Center Network (ICN), Member of the Working Group on Good Governance Practice for Research Institutions of the Council for International Organizations of Medical Sciences (CIOMS), and Advisor (Asia) of Training and Resources in Research Ethics Evaluation Program (TRREE). Henry is also devoted to consolidating and transferring practical knowledge in international clinical research management and operations and has been invited to participate as speaker, trainer or panelist in 160 conferences/forums/workshops around the world.